Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer. (Q54611172)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer. |
scientific article |
Statements
Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer. (English)
1 reference
Yung-Jue Bang
1 reference
Seock-Ah Im
1 reference
Do-Youn Oh
1 reference
Sae-Won Han
1 reference
Tae-You Kim
1 reference
Seung-Yong Jeong
1 reference
Jae-Gahb Park
1 reference
Jin Hyun Park
1 reference
Kyu Joo Park
1 reference
22 February 2011
1 reference
68
1 reference
4
1 reference
1045-1055
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference